-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LAnkXYT5nvfdPUGt82RevyUPvMtjLYkSLaCxK67kybOnjzSk1fdHAi4dNz//B1kL tfcPeN5lmkIJUeWm1S/4/A== 0000897069-07-002067.txt : 20071119 0000897069-07-002067.hdr.sgml : 20071119 20071119163442 ACCESSION NUMBER: 0000897069-07-002067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071115 FILED AS OF DATE: 20071119 DATE AS OF CHANGE: 20071119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SABEL IVAN R CENTRAL INDEX KEY: 0001217563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 071256807 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 cmw3138_ex.xml X0202 4 2007-11-15 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001217563 SABEL IVAN R TWO BETHESDA METRO CENTER SUITE 1200 BETHESDA MD 20814 1 1 0 0 CHAIRMAN OF THE BOARD, CEO Common Stock 2007-11-15 4 S 0 300 11.66 D 394846 D Common Stock 2007-11-15 4 S 0 200 11.67 D 394646 D Common Stock 1100 I Spouse's IRA Option to Buy 13.25 1998-09-19 2007-09-19 Common Stock 37500 37500 D Option to Buy 11.3125 1998-12-17 2007-12-17 Common Stock 37500 37500 D Option to Buy 22.3125 1999-12-15 2008-12-15 Common Stock 100000 100000 D Option to Buy 14.75 2000-04-29 2009-04-29 Common Stock 150000 150000 D Option to Buy 4.625 2001-02-04 2010-02-04 Common Stock 83200 83200 D Option to Buy 1.64 2002-05-31 2011-05-31 Common Stock 75000 75000 D Option to Buy 14.23 2003-05-30 2012-05-30 Common Stock 100000 100000 D Option to Buy 13.8 2004-08-01 2013-08-01 Common Stock 90000 90000 D The transactions reported on this Form 4 were the final two sales in a series of sales reported on a total of two Forms 4 filed today with the Commission. The transactions are being reported on two Forms 4 due to a limit on the number of transactions that can be reported in the EDGAR filing system on any one Form 4. Includes 105,000 shares of restricted common stock remaining from an initial grant of 140,000 shares of restricted common stock, of which 25% vested on 6/12/07 and which cumulatively vest to the extent of 25% each year thereafter, 37,500 shares of restricted common stock remaining from an initial grant of 75,000 shares of restricted common stock, of which 25% of the shares vested on each of 3/4/06 and 3/4/07 and which cumulatively vests to the extent of 25% each year thereafter, and 77,500 shares of restricted common stock, of which 25% vest on 8/9/08 and which cumulatively vest to the extent of 25% each year thereafter. This option becomes exercisable to the extent of 25% of the shares underlying the option on the above date and is cumulatively exercisable to the extent of 25% of the shares underlying the option at the end of each year thereafter. This option was fully vested on June 23, 2005. /s/ Arthur H. Bill, Attorney-in-Fact 2007-11-19 -----END PRIVACY-ENHANCED MESSAGE-----